• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自“意大利东北部血管内动脉瘤修复术后外科转换登记处”(INTRICATE)的血管内动脉瘤修复失败后开放手术转换的早期和中期结果。

Early and midterm outcomes following open surgical conversion after failed endovascular aneurysm repair from the "Italian North-easT RegIstry of surgical Conversion AfTer Evar" (INTRICATE).

作者信息

Xodo Andrea, D'Oria Mario, Squizzato Francesco, Antonello Michele, Grego Franco, Bonvini Stefano, Milite Domenico, Frigatti Paolo, Cognolato Diego, Veraldi Gian Franco, Perkmann Reinhold, Garriboli Luca, Jannello Antonio Maria, Lepidi Sandro

机构信息

Vascular and Endovascular Surgery Division, Padova University, School of Medicine, Padova, Italy.

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University of Trieste Medical School, Trieste, Italy.

出版信息

J Vasc Surg. 2022 Jan;75(1):153-161.e2. doi: 10.1016/j.jvs.2021.05.053. Epub 2021 Jun 26.

DOI:10.1016/j.jvs.2021.05.053
PMID:34182022
Abstract

OBJECTIVE

To report the early and mid-term outcomes following open surgical conversion (OSC) after failed endovascular aortic repair (EVAR) using data from a multicentric registry.

METHODS

A retrospective study was carried out on consecutive patients undergoing OSC after failed EVAR at eight tertiary vascular units from the same geographic area in the North-East of Italy, from April 2005 to November 2019. Study endpoints included early and follow-up outcomes.

RESULTS

A total of 144 consecutive patients were included in the study. Endoleaks were the most common indication for OSC (50.7%), with endograft infection (24.6%) and occlusion (21.9%) being the second most prevalent causes. The overall rate of 30-day all-cause mortality was 13.9% (n = 20); 32 patients (22.2%) experienced at least one major complication. Mean length of stay was 13 ± 12.7 days. On multivariate logistic regression, age (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.01-1-19; P = .02), renal clamping time (OR, 1.07; 95% CI, 1.02-1.13; P = .01), and suprarenal/celiac clamping (OR, 6.66; 95% CI, 1.81-27.1; P = .005) were identified as independent predictors of perioperative major complications. Age was the only factor associated with perioperative mortality at 30 days. Renal clamping time >25 minutes had sensitivity of 65% and specificity of 70% in predicting the occurring of major adverse events (area under the curve, 0.72; 95% CI, 0.61-0.82). At 5 years, estimated survival was significantly lower for patients treated due to aortic rupture/dissection (28%; 95% CI, 13%-61%), compared with patients in whom the indication for treatment was endoleak (54%; 95% CI, 40%-73%), infection (53%; 95% CI, 30%-94%), or thrombosis (82%; 95% CI, 62%-100%; P = .0019). Five-year survival rates were significantly lower in patients who received emergent treatment (28%; 95% CI, 14%-55%) as compared with those who were treated in an urgent (67%; 95% CI, 48%-93%) or elective setting (57%; 95% CI, 43%-76%; P = .00026). Subjects who received suprarenal/celiac (54%; 95% CI, 36%-82%) or suprarenal (46%; 95% CI, 34%-62%) aortic cross-clamping had lower survival rates at 5 years than those whose aortic-cross clamp site was infrarenal (76%; 95% CI, 59%-97%; P = .041). Using multivariate Cox proportional hazard, older age and emergency setting were independently associated with higher risk for overall 5-year mortality.

CONCLUSIONS

OSC after failed EVAR was associated with relatively high rates of early morbidity and mortality, particularly for emergency setting surgery. Endoleaks with secondary sac expansion were the main indication for OSC, and suprarenal aortic cross-clamping was frequently required. Endograft infection and emergent treatment remained associated with poorer short- and long-term survival.

摘要

目的

利用多中心登记处的数据报告血管腔内主动脉修复术(EVAR)失败后进行开放手术转换(OSC)的早期和中期结果。

方法

对2005年4月至2019年11月期间,意大利东北部同一地理区域的8个三级血管单元中,EVAR失败后接受OSC的连续患者进行了一项回顾性研究。研究终点包括早期和随访结果。

结果

共有144例连续患者纳入研究。内漏是OSC最常见的指征(50.7%),其次是移植物感染(24.6%)和闭塞(21.9%)。30天全因死亡率为13.9%(n = 20);32例患者(22.2%)发生至少一种主要并发症。平均住院时间为13±12.7天。多因素logistic回归分析显示,年龄(比值比[OR],1.09;95%置信区间[CI],1.01 - 1.19;P = .02)、肾动脉阻断时间(OR,1.07;95% CI,1.02 - 1.13;P = .01)和肾上/腹腔动脉阻断(OR,6.66;95% CI,1.81 - 27.1;P = .005)是围手术期主要并发症的独立预测因素。年龄是30天围手术期死亡率的唯一相关因素。肾动脉阻断时间>25分钟预测主要不良事件发生的敏感度为65%,特异度为70%(曲线下面积,(AUC)0.72;95% CI,0.61 - 0.82)。5年时,因主动脉破裂/夹层接受治疗的患者估计生存率(28%;95% CI,13% - 61%)显著低于因内漏(54%;95% CI,40% - 73%)、感染(53%;95% CI,30% - 94%)或血栓形成(82%;95% CI,62% - 100%;P = .0019)接受治疗的患者。与接受紧急治疗(28%;95% CI,14% - 55%)的患者相比,接受紧急(67%;95% CI,48% - 93%)或择期治疗(57%;95% CI,43% - 76%;P = .00026)的患者5年生存率显著降低。接受肾上/腹腔动脉(54%;95% CI,36% - 82%)或肾动脉以上(46%;95% CI,34% - 62%)主动脉交叉阻断的患者5年生存率低于肾动脉以下主动脉交叉阻断的患者(76%;95% CI,59% - 97%;P = .041)。多因素Cox比例风险分析显示,年龄较大和紧急治疗与5年总死亡率较高独立相关。

结论

EVAR失败后行OSC与相对较高的早期发病率和死亡率相关,尤其是急诊手术。继发瘤体扩张的内漏是OSC的主要指征,常需要进行肾动脉以上主动脉交叉阻断。移植物感染和急诊治疗仍然与较差的短期和长期生存率相关。

相似文献

1
Early and midterm outcomes following open surgical conversion after failed endovascular aneurysm repair from the "Italian North-easT RegIstry of surgical Conversion AfTer Evar" (INTRICATE).来自“意大利东北部血管内动脉瘤修复术后外科转换登记处”(INTRICATE)的血管内动脉瘤修复失败后开放手术转换的早期和中期结果。
J Vasc Surg. 2022 Jan;75(1):153-161.e2. doi: 10.1016/j.jvs.2021.05.053. Epub 2021 Jun 26.
2
Increasing use of open conversion for late complications after endovascular aortic aneurysm repair.血管内主动脉瘤修复后晚期并发症行开放转化治疗的应用日益增多。
J Vasc Surg. 2019 Jun;69(6):1766-1775. doi: 10.1016/j.jvs.2018.09.049. Epub 2018 Dec 21.
3
Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair.动脉瘤囊体扩张与血管内动脉瘤修复治疗患者的晚期死亡率独立相关。
J Vasc Surg. 2018 Jan;67(1):157-164. doi: 10.1016/j.jvs.2017.06.075. Epub 2017 Aug 31.
4
Elective late open conversion after endovascular aneurysm repair is associated with comparable outcomes to primary open repair of abdominal aortic aneurysms.血管内动脉瘤修复术后择期晚期开放转换与腹主动脉瘤一期开放修复的预后相当。
J Vasc Surg. 2021 Feb;73(2):502-509.e1. doi: 10.1016/j.jvs.2020.05.033. Epub 2020 May 27.
5
Late open conversion after failed endovascular aortic aneurysm repair.血管内主动脉瘤修复失败后的晚期开放转换。
J Vasc Surg. 2014 Feb;59(2):291-7. doi: 10.1016/j.jvs.2013.07.106. Epub 2013 Oct 16.
6
Late open conversions after endovascular abdominal aneurysm repair in an urgent setting.紧急情况下血管内腹主动脉瘤修复术后晚期开放转换。
J Vasc Surg. 2019 Feb;69(2):423-431. doi: 10.1016/j.jvs.2018.04.055. Epub 2018 Aug 17.
7
Endovascular aneurysm repair conversion is an increasingly common indication for open abdominal aortic aneurysm repair.血管内动脉瘤修复术转为开放手术是腹主动脉瘤开放修复术越来越常见的适应证。
J Vasc Surg. 2022 Jan;75(1):144-152.e1. doi: 10.1016/j.jvs.2021.07.121. Epub 2021 Jul 24.
8
Elective endovascular aortic repair conversion for type Ia endoleak is not associated with increased morbidity or mortality compared with primary juxtarenal aneurysm repair.与初次肾下型腹主动脉瘤修复相比,择期血管内主动脉修复转换治疗 Ia 型内漏并不增加发病率或死亡率。
J Vasc Surg. 2014 Aug;60(2):286-294.e1. doi: 10.1016/j.jvs.2014.02.046. Epub 2014 Mar 27.
9
Surgical "New Aortic Carrefour Technique" for Late Open Conversion After Endovascular Aortic Repair.血管内修复术后晚期开放转换的外科“新主动脉 Carrefour 技术”。
Ann Vasc Surg. 2021 Jan;70:434-443. doi: 10.1016/j.avsg.2020.06.027. Epub 2020 Jun 26.
10
Editor's Choice - Late Open Surgical Conversion after Endovascular Abdominal Aortic Aneurysm Repair.编辑精选 - 腹主动脉瘤腔内修复术后晚期开放手术转换。
Eur J Vasc Endovasc Surg. 2018 Feb;55(2):163-169. doi: 10.1016/j.ejvs.2017.10.011. Epub 2017 Dec 7.

引用本文的文献

1
Technical Considerations and Preliminary Experience of Intraprocedural Aneurysm Sac Embolization During Fenestrated and Branched EVAR (Embo F/BEVAR Technique): A Case Series.开窗和分支型腹主动脉瘤腔内修复术中动脉瘤囊内栓塞的技术要点及初步经验(Embo F/BEVAR技术):病例系列
J Clin Med. 2025 Apr 15;14(8):2709. doi: 10.3390/jcm14082709.
2
Intraoperative rescue of a dislodged renal stent during fenestrated endovascular aortic repair for treatment of type 1A endoleak.在开窗式血管腔内主动脉修复术治疗1A型内漏过程中对移位肾支架的术中挽救
J Vasc Surg Cases Innov Tech. 2024 Nov 20;11(1):101688. doi: 10.1016/j.jvscit.2024.101688. eCollection 2025 Feb.
3
A Retrospective Analysis of Late Open Conversions Following Failed Endovascular Aneurysm Repair.
血管内动脉瘤修复失败后晚期开放转换的回顾性分析
Rev Cardiovasc Med. 2024 Oct 10;25(10):363. doi: 10.31083/j.rcm2510363. eCollection 2024 Oct.
4
An Expert-Based Review on the Relevance and Management of Type 2 Endoleaks Following Endovascular Repair of Ruptured Abdominal Aortic Aneurysms.基于专家的腹主动脉瘤破裂血管腔内修复术后Ⅱ型内漏相关性及处理的综述
J Clin Med. 2024 Jul 23;13(15):4300. doi: 10.3390/jcm13154300.
5
Acute kidney injury after surgical treatment of failed endovascular aneurysm repair.血管内动脉瘤修复失败后手术治疗的急性肾损伤。
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Jan 29;32(1):17-25. doi: 10.5606/tgkdc.dergisi.2024.25082. eCollection 2024 Jan.
6
Peri-Operative Management of Patients Undergoing Fenestrated-Branched Endovascular Repair for Juxtarenal, Pararenal and Thoracoabdominal Aortic Aneurysms: Preventing, Recognizing and Treating Complications to Improve Clinical Outcomes.接受开窗分支型血管腔内修复术治疗近肾型、肾旁型和胸腹主动脉瘤患者的围手术期管理:预防、识别和治疗并发症以改善临床结局
J Pers Med. 2022 Jun 21;12(7):1018. doi: 10.3390/jpm12071018.